Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • f85978
    Junior Member
    • Mar 2009
    • 3

    #1

    Illumina or Solid3

    Hello, my name is Dorota. I come from Poland, but currently I am working in the Deaprtment of Genetics at King Faisla Hospital and Research Center in Riyadh. I supervise Sequencing Core Facility which is equipped with two Megabeses, two ABI 3130xl and one 3730xl. We generate up to 1500 sequencing reads per day. Our main research interest is a screening of candidate genes related to many different genetic disorders. Now we are going to get one of available NGS platforms. We are taking Illumina and Solid 3into consideration. I would be very grateful for any advices, which one will be better.
    Regards,
    Dorota
  • joa_ds
    Member
    • Dec 2008
    • 52

    #2
    if you have access to a good analysis team, take the solid. But if you have to use existing products, i'd say, go for the illumina...

    The solid produces a huge amount of data which is useless if there is noone that can write scripts and analyse it, especially with the color space. The illumina on the other hand is available with a very 'easy' pipeline, it still takes a linux guy to install and validate it, but at least you can start analysing faster than a solid run.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...